Back to Search Start Over

Assessment of poliovirus antibody seroprevalence in polio high risk areas of West Africa.

Authors :
Guindo O
Mach O
Doumbia S
Ekra DK
Beavogui AH
Weldon WC
Oberste MS
Sutter RW
Source :
Vaccine [Vaccine] 2018 Feb 14; Vol. 36 (8), pp. 1027-1031. Date of Electronic Publication: 2018 Jan 19.
Publication Year :
2018

Abstract

We conducted a serological survey of anti-polio antibodies in polio high-risk areas of Mali, Guinea and Cote d'Ivoire to assess risk of future poliovirus outbreaks. Random community sampling of children 6-11 and 36-48 months-old was conducted; neutralizing antibodies against poliovirus were detected using microneutralization assay. We analysed 1059/1064 (99.5%) of enrolled children. Seroprevalence to poliovirus type 1 (PV1) across all age groups and locations ranged between 92 and 100%, for PV2 it was 77-100%, and 89-95% for PV3. PV2 seroprevalence in the younger age group in Guinea and Cote d'Ivoire was <80%. History of <4 polio vaccine doses and acute malnutrition were associated with seronegativity (OR = 2.1 CI95% = 1.5-3.1, OR = 1.8 CI95% = 1.1-3.3 respectively). The risk of poliovirus outbreak following importation is low because of high population immunity to PV1, however, due to large cohort of PV2 seronegative children any future detection of vaccine-derived poliovirus type 2 requires urgent response to arrest rapid spread.<br /> (Copyright © 2018 Elsevier Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1873-2518
Volume :
36
Issue :
8
Database :
MEDLINE
Journal :
Vaccine
Publication Type :
Academic Journal
Accession number :
29358054
Full Text :
https://doi.org/10.1016/j.vaccine.2018.01.022